Xiaomeng Tang Selected Research

Cholecystokinin B Receptor

2/2017

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaomeng Tang Research Topics

Disease

9	Sepsis (Septicemia) 05/2024 - 01/2020
7	Neoplasms (Cancer) 01/2023 - 10/2017
3	Inflammation (Inflammations) 01/2020 - 12/2017
2	COVID-19 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 08/2022 - 09/2021
2	Edema (Dropsy) 01/2019 - 12/2017
2	Adenocarcinoma 10/2017 - 02/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2024
1	Pruritus (Itching) 04/2023
1	Malaria 04/2023
1	Hematemesis 04/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2022
1	Acute Lung Injury 02/2021
1	Rheumatoid Arthritis 01/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Lung Neoplasms (Lung Cancer) 10/2018
1	Eczema 12/2017
1	Dermatitis 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017
1	Fibrosis (Cirrhosis) 10/2013
1	Idiopathic Pulmonary Fibrosis 10/2013
1	Lung Injury 10/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2013

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	LipopolysaccharidesIBA 05/2024 - 02/2021
3	triptolideIBA 08/2022 - 01/2019
2	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2020
2	LipidsIBA 01/2020 - 01/2019
1	obeticholic acidIBA 05/2024
1	AnthelminticsIBA 04/2023
1	LuteolinIBA 01/2023
1	naringeninIBA 01/2023
1	QuercetinIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	AntigensIBA 01/2023
1	CytokinesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	HexokinaseIBA 01/2023
1	Activating Transcription Factor 4IBA 11/2022
1	Cyclic PeptidesIBA 08/2022
1	IntegrinsIBA 08/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021
1	LigandsIBA 09/2021
1	carbazoleIBA 02/2021
1	Phosphates (Orthophosphate)IBA 02/2021
1	BuffersIBA 02/2021
1	6-formylindolo(3,2-b)carbazoleIBA 02/2021
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2021
1	ProteomeIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Apolipoprotein A-VIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 10/2018
1	ProdrugsIBA 10/2018
1	MicellesIBA 10/2018
1	PolymersIBA 10/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018
1	GelsIBA 12/2017
1	Interleukin-4 (Interleukin 4)IBA 12/2017
1	FluorodeoxyuridylateIBA 10/2017
1	CalciumIBA 10/2017
1	GTP-Binding Proteins (G-Protein)IBA 02/2017
1	Cholecystokinin B ReceptorIBA 02/2017
1	Nucleotide AptamersIBA 02/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2013
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2013
1	Syndecan-2IBA 10/2013

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2013
3	Immunotherapy 01/2023 - 08/2022
2	Drug Therapy (Chemotherapy) 08/2022 - 10/2017
1	Oral Administration 01/2023
1	Ligation 11/2022
1	Punctures 11/2022
1	Biological Therapy 08/2022
1	Intravenous Injections 09/2021
1	Intraperitoneal Injections 02/2021
1	Topical Administration 01/2019
1	Cutaneous Administration 01/2019